Sera Prognostics Inc
SERA
NASDAQ
Biotechnology
$1.96
USD
-0.05 (-2.49%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $78.71M
Volume 13.5K
Revenue
$70,000
TTM
-35.2%
YoY
Gross Margin
-150%
TTM
-800.0%
YoY
Net Income
$-33.23M
TTM
-1.5%
YoY
Operating Cash Flow
$-27.68M
TTM
-5.3%
YoY
Revenue & Net Income
USD Millions
Margins Trend
Percent of revenue
Income Statement Detail
USD Millions, except per-share and share count figures
Metric | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 |
|---|---|---|---|---|---|
Revenue | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
YoY Growth | -29.2% | -44.8% | -58.3% | -63.2% | +76.5% |
Cost of Revenue | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 |
Gross Profit | -0.0 | -0.0 | -0.0 | -0.0 | -0.0 |
Selling, General & Administrative | 6.0 | 5.7 | 5.7 | 6.3 | 6.5 |
Other Operating Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Total Operating Expenses | 9.3 | 9.0 | 8.9 | 9.3 | 10.0 |
Operating Income | -9.3 | -9.0 | -9.0 | -9.4 | -10.0 |
EBITDA | -9.1 | -8.7 | -8.7 | -9.2 | -9.8 |
Other Income / Expense | 1.3 | 1.2 | 1.1 | 1.0 | 0.9 |
Total Other Income / Expense | 1.3 | 1.2 | 1.1 | 1.0 | 0.9 |
Income Before Income Taxes | -8.0 | -7.8 | -7.9 | -8.4 | -9.1 |
Income Taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Net Income | -8.0 | -7.8 | -7.9 | -8.4 | -9.1 |
Consolidated Net Income / Loss | -8.0 | -7.8 | -7.9 | -8.4 | -9.1 |
Net Income Attributable to Common Shareholders | -8.0 | -7.8 | -7.9 | -8.4 | -9.1 |
Basic EPS | -$0.16 | -$0.16 | -$0.16 | -$0.17 | -$0.18 |
Diluted EPS | -$0.16 | -$0.16 | -$0.16 | -$0.17 | -$0.18 |
Basic Shares Outstanding | 49.1M | 49.5M | 50.1M | 50.3M | 50.5M |
Diluted Shares Outstanding | 49.1M | 49.5M | 50.1M | 50.3M | 50.5M |